Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	50.24	70.29	46.78
Graham Fair Price	-5.64	32.04	33.95
PEG	645.20	-1.25	0.17
Price/Book	10.11	7.65	6.94
Price/Cash Flow	-5.17	55.53	58.55
Prices/Earnings	39.01	20.11	14.47
Price/Sales	23.65	19.93	16.12
Price/FCF	-5.17	55.53	58.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-0.58	0.56	0.57
Operating Margin	-15.43	0.25	0.29
ROA	-17.57	0.04	0.05
ROE	0.12	0.10	-20.79
ROIC	0.07	0.05	-25.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-72.10
Dividends QOQ	< 0.005	< 0.005	-60.03
EBIT QOQ	1.08	-0.20	-81.32
EPS QOQ	0.86	-0.16	-81.35
FCF QOQ	-0.28	0.23	-16.99
Revenue QOQ	0.15	-0.05	-63.62
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	130.39	133.42	2.33
Days Sales Outstanding (DSO)	31.82	29.27	-8.01
Inventory Turnover	0.69	0.67	-2.27
Debt/Capitalization	0.40	0.39	-3.62
Quick Ratio	1.70	1.85	8.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	20.66	21.91	6.02
Cash	10.80	12.40	14.81
Capex	-0.19	-0.16	14.10
Free Cash Flow	2.45	3.02	23.11
Revenue	8.90	8.41	-5.58
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.56	2.65	3.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.05	2.27	10.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating